The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 8, 2026 | Hagler Mark Arnold | Chief Commercial Officer | Grant(A) | 949K | — | $0 |
| Jul 8, 2026 | Lin Liwei Lorraine | General Counsel | Grant(A) | 255K | — | $0 |
| Jul 6, 2026 | Xu Cong Claire | SVP, Clinical Development | Sell(S) | 4K | $0.89 | $4K |
| Jul 6, 2026 | Gupta Srishti | Chief Executive Officer, Director | Grant(A) | 3.0M | — | $0 |
| Jul 4, 2026 | Xu Cong Claire | SVP, Clinical Development | Option exercise(M) | 12K | — | — |
| Jul 4, 2026 | Xu Cong Claire | SVP, Clinical Development | Option exercise(M) | 5K | — | $0 |
| Jun 29, 2026 | Fu Wei | Director | Grant(A) | 725K | — | $0 |
| Jun 29, 2026 | Fu Wei | Director | Grant(A) | 1.1M | — | $0 |
| Jun 29, 2026 | Fu Wei | Director | Grant(A) | 1.1M | — | $0 |
| Jun 29, 2026 | Fu Wei | Director | Grant(A) | 1.0M | — | $0 |
| Jun 22, 2026 | Cao Sean Wuxiong | Chief Bus. Development Officer, Director | Grant(A) | 181K | — | $0 |
| Jun 22, 2026 | Cao Sean Wuxiong | Chief Bus. Development Officer, Director | Grant(A) | 181K | — | $0 |
| Jun 18, 2026 | Dennis Phillip Andrew | Chief Medical Officer | Sell(S) | 8K | $0.66 | $6K |
| Jun 17, 2026 | Dennis Phillip Andrew | Chief Medical Officer | Option exercise(M) | 24K | — | — |
| Jun 17, 2026 | Dennis Phillip Andrew | Chief Medical Officer | Option exercise(M) | 10K | — | $0 |
| Jun 1, 2026 | Xu Cong Claire | SVP, Clinical Development | Sell(S) | 3K | $3.94 | $14K |
| May 30, 2026 | Xu Cong Claire | SVP, Clinical Development | Option exercise(M) | 9K | — | — |
| May 30, 2026 | Xu Cong Claire | SVP, Clinical Development | Option exercise(M) | 4K | — | $0 |
| May 14, 2026 | Cao Sean Wuxiong | See Remarks, Director | Sell(S) | 21K | $1.99 | $43K |
| Apr 24, 2026 | Hagler Mark Arnold | See Remarks | Buy(P) | 230K | $2.51 | $577K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-04-26 → 2026-07-11. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).